• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [22263 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Vancomycin trough for therapeutic monitoring]
2003     The Netherlands Organisation for Health Research and Development (ZonMw) [Valuing informal care in health technology assessment (HTA)]
2014     National Evidence-based Healthcare Collaborating Agency (NECA) [Valuation of EQ-5D-5L health states in Korea]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Valoctocogene roxaparvovec (haemophilia A) - Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Valoctocogen roxaparvovec (haemophilia) - Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2019     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Validity, clinical utility and safety of the next-generation sequencing (NGS) genomic platform FoundationOne® in non-small cell lung cancer and other solid tumors]
2021     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Validity of thermometers for peripheral temperature measurement]
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Validity of surrogate endpoints in oncology (Rapid report)]
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Validity of surrogate endpoints in oncology (Rapid report v. 1.1)]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Validity and cost-effectiveness of methods for screening of primary open angle glaucoma]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Validation of the FRAX fracture assessment risk tool]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Validation of the 'Trimbos and iMTA questionnaire on costs associated with psychiatric illness' (TiC-P) for measuring health care utilisation and production loss]
2009     Basque Office for Health Technology Assessment (OSTEBA) [Validation of an assessment scale of the risk of pressure ulcers in hospitalized children]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Validation of a malnutrition screening tool useful in a general hospital]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Vagus nerve stimulation for refractory epilepsy]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Vagus nerve stimulation for drug-resistant epilepsy]
2008     Haute Autorite de sante (HAS) [Vaginal myomectomy]
2011     The Swedish Council on Health Technology Assessment (SBU) [Vacuum assisted wound closure therapy]
2009     The Swedish Council on Health Technology Assessment (SBU) [Vaccines to children - protective effect and adverse events]
2010     Andalusian Health Technology Assessment Area (AETSA) [Vaccine for the prevention of herpes zoster and postherpetic neuralgia in adults]
2010     Andalusian Health Technology Assessment Area (AETSA) [Vaccine for the prevention of Alzheimer's disease]
2007     Andalusian Health Technology Assessment Area (AETSA) [Vaccine for primary prophylaxis against human papillomavirus infection]
2011     Andalusian Health Technology Assessment Area (AETSA) [Vaccine against Neisseria meningitidis serogroup B]
2010     Health Council of the Netherlands Gezondheidsraad (GR) [Vaccination of pregnant women against seasonal influenza 2010-2011]
2005     Health Council of the Netherlands Gezondheidsraad (GR) [Vaccination of infants against pneumococcal infections]
2010     Health Council of the Netherlands Gezondheidsraad (GR) [Vaccination of infants against pneumococcal infections (2)]
2003     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Vaccination for the treatment of melanoma]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Uvulopalatopharyngoplasty for snoring and obstructive sleep apnea]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [UV crosslinking with riboflavin in keratoconus]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Utilization patterns and comparative effectiveness of inhaled bronchodilators/corticosteroids for patients with chronic airway diseases]
2009     Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2009     Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2008     Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG in assessing lymphoma. Systematic review of results after chemo and immunotherapy]
2008     Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG in assessing lymphoma. Systematic review of results after chemo and immunotherapy]
2010     Andalusian Health Technology Assessment Area (AETSA) [Utility of 90Y-Ibritumomab Tiuxetan (Zevalin) in the treatment of adult patients with non-Hodgkin lymphoma]
2009     Committee for New Health Technology Assessment (CNHTA) [Uterine tamponade of postpartal bleeding by ballooning catheter]
2010     Committee for New Health Technology Assessment (CNHTA) [Uterine endometrial ablation therapy by thermal balloon]
2012     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Uterine artery embolization in patients aiming to preserve the uterus]
2011     Finnish Office for Health Care Technology Assessment (Finohta) [Uterine artery embolisation – an alternative treatment for symptomatic uterine fibroids]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Ustekinumab in Crohn’s disease]
2014     Basque Office for Health Technology Assessment (OSTEBA) [Using MitraClip® to repair mitral valve regurgitation]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Using a knee brace after reconstruction of the anterior cruciate ligament]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [User testing of IQWiG health information by socially disadvantaged people]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of video EEG for the assessment of patients with refractory epilepsy]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of urea breath test for helicobacter pylori detection]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of urea breath test for helicobacter pylori detection]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of the bilateral cochlear implant in children]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of the ALCAT test in food intolerance]
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of serum-free light chain measurement in monoclonal gammopathy]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of prometheus in severe liver failure]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of N-terminal type B natriuretic propeptide in amyloidosis]
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Usefulness of magnetic resonance imaging for the diagnosis of non-specific low back pain]
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of kinesiotaping]
2013     Basque Office for Health Technology Assessment (OSTEBA) [Usefulness of dietary treatments in Lysine metabolic disorders]
2010     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of detecting rearrangement of FIP1L1-PDGFRA in patients with primary hypereosinophilic syndrome]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of COL4A1 gene sequencing]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of a specific intra-necrotic interventional technique for the diabetic Foot]
2008     Basque Office for Health Technology Assessment (OSTEBA) [Useful strategies for promoting healthy lifestyles in primary healthcare]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of the Oncotype DX® test for therapeutic decision-making in the context of treating invasive breast cancer]
2010     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Use of telemedicine between Rigshospitalet and Bornholm Hospital: report of a pilot project]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Use of surrogate end points in HTA]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Use of statutory health insurance (BARMER) data in IQWiG's dossier assessment procedure]
2024     Basque Office for Health Technology Assessment (OSTEBA) [Use of self-sampling for the detection of human papillomavirus in cervical cancer screening]
2014     Basque Office for Health Technology Assessment (OSTEBA) [Use of radiography in diagnosing low back pain: systematic review]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of radioactive seeds for the preoperative localization of non-palpable breast tumours]
2011     Andalusian Health Technology Assessment Area (AETSA) [Use of QALYs in different clinical situations]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of prolotherapy in the treatment of chronic musculoskeletal conditions]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of medullary neurostimulators for the treatment of chronic non-cancer pain]
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of long-term left ventricular assist devices for advanced heart failure in Quebec from 2010 to 2012]
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of intravenous immunoglobulins - a review of management strategy experiences and the available evidence]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of intrathecal pumps in chronic pain management: efficacy, safety, clinical indications and organizational methods]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of intrathecal pumps for the treatment of chronic non-cancer pain]
2022     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Use of indocyanine green in colorectal and hepato-biliopancreatic surgery]
2019     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Use of incentive spirometry for the prevention of pulmonary complications following surgery]
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of Fertil ProMD products in the treatment of infertility]
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Use of class 3b and class 4 lasers and intense pulsed light sources for cosmetic procedures in non-medical settings]
2023     The Danish Health Technology Council (DHTC) [Use of artificial intelligence as clinical decision-support in colonoscopy for the diagnosis of neoplastic disease]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Use of antibiotic-loaded bone cement in primary hip and knee arthroplasty]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Use and performance of clinical mammography in Denmark]
2010     The Swedish Council on Health Technology Assessment (SBU) [Urine specimens in diagnosing chlamydia in women]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Urine proteomic analysis for detection of diabetic nephropathy in patients with diabetes mellitus and arterial hypertension]
2011     Committee for New Health Technology Assessment (CNHTA) [Urine neural thread protein]
2011     Committee for New Health Technology Assessment (CNHTA) [Urine neural thread protein test]
2009     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Urine and blood glucose self-measurement in diabetes mellitus type 2]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Urinary proteome analysis for detection of diabetic nephropathy in patients with diabetes mellitus and arterial hypertension. Update of Commission D13-01. - Rapid Report]
2013     The Swedish Council on Health Technology Assessment (SBU) [Urinary incontinence in the elderly]
2009     The Regional Health Technology Assessment Centre (HTA-centrum) [Urgent or late carotid endarterectomy in patients with symptomatic stenosis of the internal carotid artery]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Upper respiratory tract surgical techniques for the treatment of patients with obstructive sleep apnea syndrome]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Updating of the shared work system for systematic reviews of the evidence and critical appraisal (FLC 3.0 Platform)]
2014     Andalusian Health Technology Assessment Area (AETSA) [Updating of selection criteria for direct antiviral agents for patients with chronic hepatitis c in a severe clinical situation in the SSPA]
2023     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Update: Functioning and disability - An evidence map]
2009     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Update search on Report A05-19A (cholinesterase inhibitors in the treatment of Alzheimer's Disease) - Rapid report]
2023     Austrian Institute for Health Technology Assessment (AIHTA) [Update PET/PET-CT evidence for need based planning in the area of oncology]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Update of the guideline synopsis for the DMP "rheumatoid arthritis" - rapid report]
2007     Andalusian Health Technology Assessment Area (AETSA) [Update of the guide for the introduction of new drugs (GINF)]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (ulcerative colitis) - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (rheumatoid arthritis) - Benefit assessment according to §35a Social Code Book V]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (psoriatic arthritis) - Benefit assessment according to §35a Social Code Book V]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (psoriatic arthritis) - Addendum to Commission A21-15]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (Crohn disease) - Benefit assessment according to §35a Social Code Book V]